Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New dream remote aims to banish Children's nightmares

NCT ID NCT06410118

Symptom relief Sponsor: Tel Aviv University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a special remote control (DreamChanger) plus a simple bedtime therapy can help children aged 3-10 have fewer nightmares. Parents guide their child through the program at home using instructional videos. The trial involves 120 children and compares the DreamChanger group to a waitlist. Results will measure nightmare frequency, sleep quality, and child behavior.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
DreamChanger remote device and imagery rehearsal therapy (behavioral intervention)
What this could lead to
If it works, this could give families a simple, non-drug tool to reduce children's nightmares and improve sleep.
What could go wrong
This is a small, early-stage trial with no blinding, and results rely on parent reports. The intervention may not work for all children or have lasting effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 10 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * child aged 3-10 years * parents aged over 18 years * child experiencing distressing nightmares at least once per week on average, for at least 1 month. Exclusion Criteria: * Child receiving concurrent treatment for nightmares, sleep, or anxiety * Child diagnosed with a medical sleep problem (e.g., OSA, RLS)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nightmare are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Nightmare

Contacts and locations

Locations

  • Tel Aviv University

    Tel Aviv, Israel, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.